Annalisa Na

Dr. Annalisa Na


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Open access
ANAnnalisa Na
Annalisa Na
AMAddie Middleton
Addie Middleton
AHAllen Haas
Allen Haas
JGJames E Graham
James E Graham
KOKenneth J. Ottenbacher
Kenneth J. Ottenbacher
Background: In an effort to improve quality and reduce costs, reimbursement for total knee arthroplasty (TKA) and total hip arthroplasty (THA) in the United States is being based on the value of care provided, with adjustments for some qualifying comorbidities, including diabetes in its most severe form and excluding many diabetes codes. The aims of this study were to examine the effects of diabetes on elective TKA or THA complications and readmission risks among Medicare beneficiaries. Methods: Complication (n = 521,230) and readmission (n = 515,691) data were extracted from Medicare files in 2013 and 2014. Diabetes status (no diabetes, controlled-uncomplicated diabetes, controlled-complicated diabetes, and uncontrolled diabetes) was identified with ICD-9 (International Classification of Diseases, 9th Revision) codes. TKA or THA complications and readmission odds based on diabetes status were estimated using logistic regression and adjusted for sociodemographic and clinical characteristics, including comorbidities. Results: Compared with no diabetes, the odds ratio (OR) of TKA complications was significantly higher for uncontrolled diabetes (1.29, 95% confidence interval [CI] = 1.06 to 1.57). The OR of THA complications was significantly higher for controlled-complicated diabetes (1.45, 95% CI = 1.17 to 1.80). The OR of readmission was significantly higher for all diabetes groups (1.21 to 1.48 for TKA, 1.20 to 1.70 for THA). Conclusions: Readmission odds were higher in all diabetes categories. The uncontrolled-diabetes group had the greatest TKA readmission and complication odds. The controlled-complicated diabetes group had the greatest THA readmission and complication odds. The findings suggest that including diabetes and associated systemic complications in cost adjustments in alternative payment models for arthroplasty should be considered. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 March 2018 in Gait & Posture
Verified
Journal Article
Closed access
ANAnnalisa Na
Annalisa Na
SPSara R Piva
Sara R Piva
TBThomas S. S Buchanan
Thomas S. S Buchanan



1 June 2021 in Journal of Orthopaedic & Sports Physical Therapy
Verified
Journal Article
Closed access
ANAnnalisa Na
Annalisa Na
LOLaura M. Oppermann
Laura M. Oppermann
DJDaniel Jupiter
Daniel Jupiter
RLRonald W. Lindsey
Ronald W. Lindsey
RCRogelio A. Coronado
Rogelio A. Coronado
Objective: To compare physical function, pain, impairments (stiffness, range of motion, and strength), and health-related quality of life (HRQoL) outcomes between patients with and without diabetes mellitus, before and after a total knee arthroplasty (TKA). Design: Prognosis systematic review. Literature Search: We searched MEDLINE/PubMed, CINAHL, SPORTDiscus, and Web of Science to August 2019. Study Selection Criteria: We included longitudinal studies that examined physical function, pain, impairments, and HRQoL outcomes among patients receiving a TKA and with or without diabetes. Data Synthesis: For quantitative synthesis, we stratified outcomes based on time relative to TKA: preoperative, less than 1 year after a TKA (early postoperative), and 1 year or more after a TKA (late postoperative). We used random-effects meta-analysis to calculate standardized mean differences (SMDs) and 95% confidence intervals (CIs). We used the Grading of Recommendations Assessment, Development and Evaluation system for qualitative synthesis. Results: We included 21 studies (n = 17 472 patients). Patients with diabetes mellitus had worse preoperative physical function (SMD, −0.16; 95% CI: −0.24, −0.08) and HRQoL (SMD, −0.16; 95% CI: −0.26, −0.05), worse early postoperative pain (SMD, −0.22; 95% CI: −0.39, −0.05) and strength (SMD, −0.45; 95% CI: −0.77, −0.14), and worse late postoperative physical function (SMD, −0.23; 95% CI: −0.40, −0.06), range of motion (SMD, −0.23; 95% CI: −0.46, 0.00), and HRQoL (SMD, −0.19; 95% CI: −0.29, −0.08) than patients without diabetes mellitus. The overall risk of bias across studies was high, and the certainty of evidence ranged from low to very low. Conclusion: Patients with diabetes mellitus had worse patient-reported and clinician-assessed outcomes before and after a TKA. Given the limitations of included studies, these results may change with future research. J Orthop Sports Phys Ther 2021;51(6):269–280. Epub 19 Apr 2021. doi:10.2519/jospt.2021.9515

19 November 2019 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
ANAnnalisa Na
Annalisa Na
LJLaurie Jansky
Laurie Jansky
ZGZbigniew Gugala
Zbigniew Gugala
Aim. The purpose of this study is to explore clinical characteristics of patients with T2DM receiving a primary knee (TKA) or hip (THA) arthroplasty to patients without T2DM receiving a TKA or THA and patients with T2DM with no history of osteoarthritis (OA). Methods. The study included a retrospective database review of 500 consecutive primary TKA or THA identified with ICD-9 codes and 100 consecutive T2DM patients. Patients who received a TKA or THA were screened for inclusion and exclusion and divided into with or without T2DM groups. A comparison group of patients with T2DM only without arthroplasty was screened to exclude patients with a history of OA or arthroplasty. All groups were compared based on demographic and relevant comorbidity differences. OA characteristics, including OA and previous arthroplasty of the involved and contralateral joints, were compared between patients with and without T2DM receiving a TKA or THA. Finally, patients with T2DM with and without TKA or THA were compared for T2DM differences. Results. Study results found that among those receiving a primary arthroplasty, patients with T2DM were more likely to be obese and older and reported cardiovascular, urinary, dyslipidemia, and peripheral neuropathy than those with T2DM. Among the T2DM individuals, those receiving an arthroplasty surgery were older and obese and more likely to report peripheral neuropathy; however, those with T2DM with no OA were more likely to report atherosclerosis and cardiovascular disease. Within the arthroplasty subgroup of individuals with T2DM, those requiring antidiabetic medication were 4.5 times more likely to have contralateral OA or arthroplasty. Conclusions. The results of this study suggest that patients with T2DM requiring a primary arthroplasty are a unique subgroup that requires careful considerations as they are often older, have obesity, and specific comorbidities predisposing to worse postoperative outcomes than their non-T2DM arthroplasty counterparts. Therefore, clinical practice and future studies must consider strategies that would limit OA and arthroplasty management delays while accounting for comorbidities and patient characteristics.